The global Infantile Spasm Treatment market was valued at US$ 140 million in 2023 and is anticipated to reach US$ 184.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.

Infantile Spasm Treatment Market

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Infantile Spasm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infantile Spasm Treatment.

Report Scope

The Infantile Spasm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infantile Spasm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infantile Spasm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Infantile Spasm Treatment Market Report

Report Metric	Details
Report Name	Infantile Spasm Treatment Market
Accounted market size in 2023	US$ 140 million
Forecasted market size in 2030	US$ 184.8 million
CAGR	3.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oral Parenteral
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin, GW Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infantile Spasm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infantile Spasm Treatment Market growing?

Ans: The Infantile Spasm Treatment Market witnessing a CAGR of 3.6% during the forecast period 2024-2030.

What is the Infantile Spasm Treatment Market size in 2030?

Ans: The Infantile Spasm Treatment Market size in 2030 will be US$ 184.8 million.

Who are the main players in the Infantile Spasm Treatment Market report?

Ans: The main players in the Infantile Spasm Treatment Market are Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin, GW Pharmaceuticals

What are the Application segmentation covered in the Infantile Spasm Treatment Market report?

Ans: The Applications covered in the Infantile Spasm Treatment Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Infantile Spasm Treatment Market report?

Ans: The Types covered in the Infantile Spasm Treatment Market report are Oral, Parenteral

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infantile Spasm Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Parenteral

1.3 Market by Application

1.3.1 Global Infantile Spasm Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infantile Spasm Treatment Market Perspective (2019-2030)

2.2 Infantile Spasm Treatment Growth Trends by Region

2.2.1 Global Infantile Spasm Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Infantile Spasm Treatment Historic Market Size by Region (2019-2024)

2.2.3 Infantile Spasm Treatment Forecasted Market Size by Region (2025-2030)

2.3 Infantile Spasm Treatment Market Dynamics

2.3.1 Infantile Spasm Treatment Industry Trends

2.3.2 Infantile Spasm Treatment Market Drivers

2.3.3 Infantile Spasm Treatment Market Challenges

2.3.4 Infantile Spasm Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infantile Spasm Treatment Players by Revenue

3.1.1 Global Top Infantile Spasm Treatment Players by Revenue (2019-2024)

3.1.2 Global Infantile Spasm Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Infantile Spasm Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Infantile Spasm Treatment Revenue

3.4 Global Infantile Spasm Treatment Market Concentration Ratio

3.4.1 Global Infantile Spasm Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infantile Spasm Treatment Revenue in 2023

3.5 Infantile Spasm Treatment Key Players Head office and Area Served

3.6 Key Players Infantile Spasm Treatment Product Solution and Service

3.7 Date of Enter into Infantile Spasm Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Infantile Spasm Treatment Breakdown Data by Type

4.1 Global Infantile Spasm Treatment Historic Market Size by Type (2019-2024)

4.2 Global Infantile Spasm Treatment Forecasted Market Size by Type (2025-2030)

5 Infantile Spasm Treatment Breakdown Data by Application

5.1 Global Infantile Spasm Treatment Historic Market Size by Application (2019-2024)

5.2 Global Infantile Spasm Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Infantile Spasm Treatment Market Size (2019-2030)

6.2 North America Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Infantile Spasm Treatment Market Size by Country (2019-2024)

6.4 North America Infantile Spasm Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infantile Spasm Treatment Market Size (2019-2030)

7.2 Europe Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Infantile Spasm Treatment Market Size by Country (2019-2024)

7.4 Europe Infantile Spasm Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Infantile Spasm Treatment Market Size (2019-2030)

8.2 Asia-Pacific Infantile Spasm Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Infantile Spasm Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Infantile Spasm Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Infantile Spasm Treatment Market Size (2019-2030)

9.2 Latin America Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Infantile Spasm Treatment Market Size by Country (2019-2024)

9.4 Latin America Infantile Spasm Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infantile Spasm Treatment Market Size (2019-2030)

10.2 Middle East & Africa Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Infantile Spasm Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Infantile Spasm Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Mallinckrodt

11.1.1 Mallinckrodt Company Detail

11.1.2 Mallinckrodt Business Overview

11.1.3 Mallinckrodt Infantile Spasm Treatment Introduction

11.1.4 Mallinckrodt Revenue in Infantile Spasm Treatment Business (2019-2024)

11.1.5 Mallinckrodt Recent Development

11.2 H. Lundbeck

11.2.1 H. Lundbeck Company Detail

11.2.2 H. Lundbeck Business Overview

11.2.3 H. Lundbeck Infantile Spasm Treatment Introduction

11.2.4 H. Lundbeck Revenue in Infantile Spasm Treatment Business (2019-2024)

11.2.5 H. Lundbeck Recent Development

11.3 Insys Therapeutics

11.3.1 Insys Therapeutics Company Detail

11.3.2 Insys Therapeutics Business Overview

11.3.3 Insys Therapeutics Infantile Spasm Treatment Introduction

11.3.4 Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024)

11.3.5 Insys Therapeutics Recent Development

11.4 Orphelia Pharma

11.4.1 Orphelia Pharma Company Detail

11.4.2 Orphelia Pharma Business Overview

11.4.3 Orphelia Pharma Infantile Spasm Treatment Introduction

11.4.4 Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2019-2024)

11.4.5 Orphelia Pharma Recent Development

11.5 Valerion Therapeutics

11.5.1 Valerion Therapeutics Company Detail

11.5.2 Valerion Therapeutics Business Overview

11.5.3 Valerion Therapeutics Infantile Spasm Treatment Introduction

11.5.4 Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024)

11.5.5 Valerion Therapeutics Recent Development

11.6 Catalyst Pharmaceuticals

11.6.1 Catalyst Pharmaceuticals Company Detail

11.6.2 Catalyst Pharmaceuticals Business Overview

11.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Introduction

11.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024)

11.6.5 Catalyst Pharmaceuticals Recent Development

11.7 Anavex Life Sciences

11.7.1 Anavex Life Sciences Company Detail

11.7.2 Anavex Life Sciences Business Overview

11.7.3 Anavex Life Sciences Infantile Spasm Treatment Introduction

11.7.4 Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2019-2024)

11.7.5 Anavex Life Sciences Recent Development

11.8 Retrophin

11.8.1 Retrophin Company Detail

11.8.2 Retrophin Business Overview

11.8.3 Retrophin Infantile Spasm Treatment Introduction

11.8.4 Retrophin Revenue in Infantile Spasm Treatment Business (2019-2024)

11.8.5 Retrophin Recent Development

11.9 GW Pharmaceuticals

11.9.1 GW Pharmaceuticals Company Detail

11.9.2 GW Pharmaceuticals Business Overview

11.9.3 GW Pharmaceuticals Infantile Spasm Treatment Introduction

11.9.4 GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024)

11.9.5 GW Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Valerion Therapeutics

Catalyst Pharmaceuticals

Anavex Life Sciences

Retrophin

GW Pharmaceuticals

List of Tables

Table 1. Global Infantile Spasm Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Parenteral

Table 4. Global Infantile Spasm Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Infantile Spasm Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Infantile Spasm Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Infantile Spasm Treatment Market Share by Region (2019-2024)

Table 8. Global Infantile Spasm Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Infantile Spasm Treatment Market Share by Region (2025-2030)

Table 10. Infantile Spasm Treatment Market Trends

Table 11. Infantile Spasm Treatment Market Drivers

Table 12. Infantile Spasm Treatment Market Challenges

Table 13. Infantile Spasm Treatment Market Restraints

Table 14. Global Infantile Spasm Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Infantile Spasm Treatment Market Share by Players (2019-2024)

Table 16. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasm Treatment as of 2023)

Table 17. Ranking of Global Top Infantile Spasm Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Infantile Spasm Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Infantile Spasm Treatment Product Solution and Service

Table 21. Date of Enter into Infantile Spasm Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Infantile Spasm Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Infantile Spasm Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Infantile Spasm Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Infantile Spasm Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Infantile Spasm Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Infantile Spasm Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Infantile Spasm Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Infantile Spasm Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Infantile Spasm Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Infantile Spasm Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Infantile Spasm Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Mallinckrodt Company Detail

Table 47. Mallinckrodt Business Overview

Table 48. Mallinckrodt Infantile Spasm Treatment Product

Table 49. Mallinckrodt Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 50. Mallinckrodt Recent Development

Table 51. H. Lundbeck Company Detail

Table 52. H. Lundbeck Business Overview

Table 53. H. Lundbeck Infantile Spasm Treatment Product

Table 54. H. Lundbeck Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 55. H. Lundbeck Recent Development

Table 56. Insys Therapeutics Company Detail

Table 57. Insys Therapeutics Business Overview

Table 58. Insys Therapeutics Infantile Spasm Treatment Product

Table 59. Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 60. Insys Therapeutics Recent Development

Table 61. Orphelia Pharma Company Detail

Table 62. Orphelia Pharma Business Overview

Table 63. Orphelia Pharma Infantile Spasm Treatment Product

Table 64. Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 65. Orphelia Pharma Recent Development

Table 66. Valerion Therapeutics Company Detail

Table 67. Valerion Therapeutics Business Overview

Table 68. Valerion Therapeutics Infantile Spasm Treatment Product

Table 69. Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 70. Valerion Therapeutics Recent Development

Table 71. Catalyst Pharmaceuticals Company Detail

Table 72. Catalyst Pharmaceuticals Business Overview

Table 73. Catalyst Pharmaceuticals Infantile Spasm Treatment Product

Table 74. Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 75. Catalyst Pharmaceuticals Recent Development

Table 76. Anavex Life Sciences Company Detail

Table 77. Anavex Life Sciences Business Overview

Table 78. Anavex Life Sciences Infantile Spasm Treatment Product

Table 79. Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 80. Anavex Life Sciences Recent Development

Table 81. Retrophin Company Detail

Table 82. Retrophin Business Overview

Table 83. Retrophin Infantile Spasm Treatment Product

Table 84. Retrophin Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 85. Retrophin Recent Development

Table 86. GW Pharmaceuticals Company Detail

Table 87. GW Pharmaceuticals Business Overview

Table 88. GW Pharmaceuticals Infantile Spasm Treatment Product

Table 89. GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)

Table 90. GW Pharmaceuticals Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infantile Spasm Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Infantile Spasm Treatment Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Parenteral Features

Figure 5. Global Infantile Spasm Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Infantile Spasm Treatment Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Other Case Studies

Figure 10. Infantile Spasm Treatment Report Years Considered

Figure 11. Global Infantile Spasm Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Infantile Spasm Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Infantile Spasm Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Infantile Spasm Treatment Market Share by Players in 2023

Figure 15. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasm Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Infantile Spasm Treatment Revenue in 2023

Figure 17. North America Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Infantile Spasm Treatment Market Share by Country (2019-2030)

Figure 19. United States Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Infantile Spasm Treatment Market Share by Country (2019-2030)

Figure 23. Germany Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Infantile Spasm Treatment Market Share by Region (2019-2030)

Figure 31. China Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Infantile Spasm Treatment Market Share by Country (2019-2030)

Figure 39. Mexico Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Infantile Spasm Treatment Market Share by Country (2019-2030)

Figure 43. Turkey Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Mallinckrodt Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 46. H. Lundbeck Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 47. Insys Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 48. Orphelia Pharma Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 49. Valerion Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 50. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 51. Anavex Life Sciences Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 52. Retrophin Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 53. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Tardive Dystonia Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18L14247

Wed Aug 14 00:00:00 UTC 2024

Add to Cart

Global Disjointed Aneurysm Clip Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25Z14384

Wed Aug 14 00:00:00 UTC 2024

Add to Cart

Global Amyotrophic Lateral Sclerosis (ALS) Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34J15350

Tue Aug 13 00:00:00 UTC 2024

Add to Cart

Global Visual Electrodiagnostic System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29Y17645

Tue Aug 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions